The Commodification of Human Traits: Market Dynamics in the Genomic Economy

Joshua Luberisse

No h39za_v1, SocArXiv from Center for Open Science

Abstract: This article theorizes the emergence of a genomic marketplace in which traits—from disease resistance to enhanced cognition—are priced, licensed, and traded as proprietary assets. We introduce two mechanisms that organize value capture in this economy: inherited revenue assurance (IRA), a lineage-binding royalty structure for germline edits, and genomic asset–backed securities (GABS), financial instruments that securitize expected royalty cashflows from edited populations. We build a conceptual model of the trait value chain—from IP origination through multigenerational licensing and secondary finance—and analyze distributional and ethical consequences under competing regulatory regimes (patent exclusivity, FRAND-style licensing, royalty caps, and trait commons). The contribution is a political–economy account that connects molecular IP to household welfare and macro–finance, while offering policy tests that distinguish emancipatory from extractive designs.

Date: 2025-08-06
References: Add references at CitEc
Citations:

Downloads: (external link)
https://osf.io/download/68931a32efb80aeb5450eeac/

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:osf:socarx:h39za_v1

DOI: 10.31219/osf.io/h39za_v1

Access Statistics for this paper

More papers in SocArXiv from Center for Open Science
Bibliographic data for series maintained by OSF ().